Dr. Agarwal's Health Care: Scheme of Amalgamation Effective Nov 1, Record Date Nov 18
Dr. Agarwal's Health Care Limited's Board approved the Scheme of Amalgamation, effective November 1, 2026. The NCLT order was filed on October 15, 2026. The Record Date for share allotment is November 18, 2026, with an exchange ratio of 23:2.
An amalgamation is a significant corporate event that fundamentally alters the company's structure and operations, impacting shareholders and stakeholders considerably.
The announcement details the successful progression and effectiveness of a scheme of amalgamation, which is a positive corporate action for growth and consolidation.
Dr. Agarwal's Health Care Limited announced that its Board of Directors, in a meeting held on October 20, 2026, approved key aspects of the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited.
The Board took on record the certified copy of the National Company Law Tribunal (NCLT) order dated September 30, 2026, sanctioning the Scheme. Following the filing of this order with the Registrar of Companies on October 15, 2026, all conditions for the Scheme's effectiveness have been met. The Scheme will officially become effective from November 1, 2026, with the Appointed Date set as April 1, 2026.
Additionally, the Board approved the alteration of the authorized share capital. The existing authorized share capital of Dr. Agarwal’s Eye Hospital Limited will be reclassified, and upon the Scheme's effectiveness, it will be merged with the authorized share capital of Dr. Agarwal’s Health Care Limited. This will increase the authorized equity share capital from ₹54,20,00,000 to ₹74,20,00,000, and the total authorized capital from ₹90,00,00,000 to ₹110,00,00,000.
The Board also fixed Wednesday, November 18, 2026, as the Record Date for determining the equity shareholders of Dr. Agarwal’s Eye Hospital Limited who are eligible to receive consideration shares. The share exchange ratio is set at 23 Equity Shares of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 Equity Shares of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited. The board meeting commenced at 05:30 P.M. IST and concluded at 06:00 P.M. IST.
What to do with a filing like this
Dr. Agarwal's Health Care Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Agarwal's Health Care Limited. Read the original for the full detail.